Venmax Drugs (531015)

FAST GROWER

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹4.18
Market Cap₹2.19 Cr
P/E Ratio25.63
ROCE5.29%
ROE-92.31%
Dividend Yield0%
Profit Growth106%
Debt/Equity—
Sales Growth675%
52-Week Range₹19.01 — ₹36.96
SectorPharmaceuticals & Biotechnology

Venmax Drugs trades with a P/E ratio of 25.63, ROCE of 5.29%, ROE of -92.31%, profit growth of 106%.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer